Cargando…

Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment

PURPOSE: Hepatocellular carcinoma (HCC) patients usually achieve a complete response after treatment. This study was aimed to assess the clinical outcome of HCC patients who had achieved a complete response but later presented with elevated tumor marker levels without an identifiable recurrent tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ka Eun, Sinn, Dong Hyun, Choi, Moon Seok, Kim, Honsoul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794219/ https://www.ncbi.nlm.nih.gov/pubmed/35085305 http://dx.doi.org/10.1371/journal.pone.0262750

Ejemplares similares

Histogram Analysis of Gadoxetic Acid-Enhanced MRI for Quantitative Hepatic Fibrosis Measurement
por: Kim, Honsoul, et al.
Publicado: (2014)

Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI
por: Park, Seung Hyun, et al.
Publicado: (2017)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
por: Ricke, Jens, et al.
Publicado: (2020)

Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI
por: Kim, Seung Hyun, et al.
Publicado: (2013)

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI
por: Song, Kyoung Doo, et al.
Publicado: (2015)

Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI
por: Palm, Viktoria, et al.
Publicado: (2018)

A rare case of MRI of myxoid hepatocellular adenoma with gadoxetic acid uptake
por: Yang, Tze Wei Wilson, et al.
Publicado: (2023)

Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI
por: Moon, Ji Yoon, et al.
Publicado: (2021)

Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria
por: Park, Jae Hyon, et al.
Publicado: (2020)

Quantification of liver function using gadoxetic acid-enhanced MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2020)

Analysis of the Performance of Gadoxetic Acid Disodium MRI in Predicting Microvascular Invasion of Hepatocellular Carcinoma
por: Chen, Jiao, et al.
Publicado: (2022)

Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced MRI versus Gadobenate Dimeglumine (Gd-BOPTA)-Enhanced MRI for Preoperatively Detecting Hepatocellular Carcinoma: an Initial Experience
por: Park, Yulri, et al.
Publicado: (2010)

The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
por: Kim, Jung Hee, et al.
Publicado: (2016)

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
por: Kim, Yeun-Yoon, et al.
Publicado: (2019)

Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials
por: Huh, Jimi, et al.
Publicado: (2019)

Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
por: Islam, S, et al.
Publicado: (2015)

Usefulness of Arterial Subtraction in Applying Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Algorithm to Gadoxetic Acid-Enhanced MRI
por: Youn, Seo Yeon, et al.
Publicado: (2021)

Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study
por: Zhou, Meng, et al.
Publicado: (2021)

Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI
por: Jiang, Hanyu, et al.
Publicado: (2022)

Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5 cm on gadoxetate disodium-enhanced MRI
por: Yang, Ting, et al.
Publicado: (2023)

The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI
por: Yoshida, Morikatsu, et al.
Publicado: (2020)

Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer
por: Hwang, Jeong Ah, et al.
Publicado: (2022)

Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology
Publicado: (2017)

Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study
por: Rao, Chenyi, et al.
Publicado: (2020)

Prediction of Decompensation and Death in Advanced Chronic Liver Disease Using Deep Learning Analysis of Gadoxetic Acid-Enhanced MRI
por: Heo, Subin, et al.
Publicado: (2022)

Role of gadoxetic acid-enhanced 3T MRI combined with diffusion in small HCC diagnosis - case presentation
por: GHEONEA, I.A., et al.
Publicado: (2015)

Second-line Sonazoid-enhanced ultrasonography for Liver Imaging Reporting and Data System category 3 and 4 on gadoxetate-enhanced magnetic resonance imaging
por: Kim, Yeun-Yoon, et al.
Publicado: (2022)

Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30° Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastasis
por: Lee, Dahye, et al.
Publicado: (2015)

Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases
por: Zech, C J, et al.
Publicado: (2014)

Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors
por: Ryeom, Hunkyu, et al.
Publicado: (2023)

Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure
por: Zhu, Wang-Shu, et al.
Publicado: (2020)

Deep Learning-Based Assessment of Functional Liver Capacity Using Gadoxetic Acid-Enhanced Hepatobiliary Phase MRI
por: Park, Hyo Jung, et al.
Publicado: (2022)

Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition
por: Ulloa, Jose L, et al.
Publicado: (2013)

Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study
por: Ye, Zheng, et al.
Publicado: (2019)

Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma
por: Qiu, Ganbin, et al.
Publicado: (2023)

Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging
por: Kim, Jae Hyun, et al.
Publicado: (2019)

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: Correlation with pathology and dynamic CT
por: Kim, Bohyun, et al.
Publicado: (2018)

Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
por: Wang, Qiang, et al.
Publicado: (2021)

Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid–enhanced liver MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3c0lmm83omqr4g3jc89g7cktqm